Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy Plus Cystectomy vs Cystectomy Alone for cT0 Muscle-invasive Bladder Cancer
NCT05776758Phase 3Active, not recruiting
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- Aug 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in muscle-invasive bladder cancer (MIBC), sponsored by IRCCS Regina Elena National Cancer Institute. Started Aug 2026; status: active, not recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
muscle-invasive bladder cancer (MIBC)
Beyond the preview
Go deeper on NCT05776758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05776758.